`
`
`
`
`
`
`
`
`Before the Patent Trial and Appeal Board
`
`AMERIGEN PHARMACEUTICALS LIMITED,
`
`Petitioner
`
`v.
`
`UCB PHARMA GMBH
`
`
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 6,858,650
`Filing Date: November 15, 2000
`Issue Date: February 22, 2005
`Title: STABLE SALTS OF NOVEL DERIVATIVES
`OF 3,3-DIPHENYLPROPYLAMINES
`
`
`
`
`
`
`
`Title: COMPOSITIONS AND METHODS FOR TREATMENT OF BOWEL
`
`DISEASES WITH GRANULATED MESALAMINE
`Inter Partes Review No.: Unassigned
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF WORD COUNT OF PETITION FOR
`INTER PARTES REVIEW
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.24(c) and (d), Petitioner certifies that the word count
`
`of Amerigen Pharmaceuticals Limited’s Petition for Inter Partes Review (exclusive of
`
`any table of contents, table of authorities, mandatory notices under §42.8, certificate of
`
`service or word count, or appendix of exhibits or claim listing) as measured by
`
`Microsoft Word is 12,480 words.
`
`Respectfully submitted,
`
`By: /s/William D. Hare/
`William D. Hare
`Reg. No. 44,739
`
`
`
`2
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.105(a), I certify that on August 22, 2016, I
`
`caused to be served true and correct copy of this document by overnight courier on the
`
`Patent Owner at the correspondence address of the Patent Owner, as follows:
`
`Jeffrey Ginsberg
`Kenyon & Kenyon LLP
`One Broadway
`New York, New York 10004-1007
`
`with a courtesy copy to counsel for Pfizer Inc. and UCB Pharma GMBH, as follows:
`
`
`
`
`
`Jack Blumenfeld
`Morris, Nichols, Arsht & Tunnell LLP
`1201 North Market Street
`Wilmington, DE 19899
`
`Dimitrios T. Drivas
`Jeffrey J. Oelke
`James S. Trainor, Jr.
`Ryan P. Johnson
`Robert Counihan
`WHITE &CASE LLP
`1155 Avenue of the Americas
`New York, NY 10036
`
`
`
`By: /s/William D. Hare/
`William D. Hare
`
`
`
`3